203 related articles for article (PubMed ID: 27598890)
1. Management of proliferative lupus nephritis.
Monroy Trujillo JM; Fine DM
Panminerva Med; 2016 Dec; 58(4):286-293. PubMed ID: 27598890
[TBL] [Abstract][Full Text] [Related]
2. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
Sixdorf U; Bauer H; Märker-Hermann E
Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
[TBL] [Abstract][Full Text] [Related]
3. Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis.
van Tellingen A; Voskuyl AE; Vervloet MG; Bijl M; de Sévaux RG; Berger SP; Derksen RH; Berden JH;
Neth J Med; 2012 May; 70(4):199-207. PubMed ID: 22641632
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil for lupus nephritis: an update.
Mok CC
Expert Rev Clin Immunol; 2015; 11(12):1353-64. PubMed ID: 26364748
[TBL] [Abstract][Full Text] [Related]
5. Updates on the treatment of lupus nephritis.
Bomback AS; Appel GB
J Am Soc Nephrol; 2010 Dec; 21(12):2028-35. PubMed ID: 21051743
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological therapy of lupus nephritis.
Fine DM
JAMA; 2005 Jun; 293(24):3053-60. PubMed ID: 15972568
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for severe lupus nephritis.
Lenz O; Contreras G
Arch Immunol Ther Exp (Warsz); 2004; 52(5):356-65. PubMed ID: 15507877
[TBL] [Abstract][Full Text] [Related]
8. Initial management of proliferative lupus nephritis: to cytotoxic or not to cytotoxic?
Belmont HM
Curr Rheumatol Rep; 1999 Dec; 1(2):87-8. PubMed ID: 11123020
[No Abstract] [Full Text] [Related]
9. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
Ong LM; Hooi LS; Lim TO; Goh BL; Ahmad G; Ghazalli R; Teo SM; Wong HS; Tan SY; Shaariah W; Tan CC; Morad Z
Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
[TBL] [Abstract][Full Text] [Related]
11. [Lupus-nephritis--diagnosis and treatment].
Norby GE; Lerang K; Holdaas H; Gran JT; Strøm EH; Draganov B; Os I; Hartmann A; Gilboe IM
Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1140-4. PubMed ID: 20531500
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
[TBL] [Abstract][Full Text] [Related]
13. Which dose of steroids and which cytotoxics for severe lupus?
Lutalo PM; Jordan N; D'Cruz DP
Presse Med; 2014 Jun; 43(6 Pt 2):e157-65. PubMed ID: 24882275
[TBL] [Abstract][Full Text] [Related]
14. The safety of pharmacological treatment options for lupus nephritis.
Velo-García A; Ntatsaki E; Isenberg D
Expert Opin Drug Saf; 2016 Aug; 15(8):1041-54. PubMed ID: 27159360
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566
[TBL] [Abstract][Full Text] [Related]
16. How did cyclophosphamide become the drug of choice for lupus nephritis?
Bargman JM
Nephrol Dial Transplant; 2009 Feb; 24(2):381-4. PubMed ID: 19056783
[No Abstract] [Full Text] [Related]
17. Lupus nephritis: treatment with mycophenolate mofetil.
Kapitsinou PP; Boletis JN; Skopouli FN; Boki KA; Moutsopoulos HM
Rheumatology (Oxford); 2004 Mar; 43(3):377-80. PubMed ID: 14963204
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive Treatment for Proliferative Lupus Nephritis: Summary of a Cochrane Review.
Tunnicliffe DJ; Palmer SC
Am J Kidney Dis; 2018 Nov; 72(5):756-757. PubMed ID: 30343732
[No Abstract] [Full Text] [Related]
20. Induction and maintenance therapy in proliferative lupus nephritis.
Ponticelli C; Glassock RJ; Moroni G
J Nephrol; 2010; 23(1):9-16. PubMed ID: 20091481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
